debate: molecular tests should be performed routinely for elderly patients with cytopenias/mds - yes
Published 7 years ago • 217 plays • Length 18:11Download video MP4
Download video MP3
Similar videos
-
4:00
when should genetic testing for mds be done?
-
9:07
debate: should consolidation and minimal residual disease testing be used? - no
-
4:37
relaza2 results: azacitidine use in mds & aml | anne sophie kubasch, md | eha 2024
-
20:17
role of immune system in mds pathogenesis
-
12:26
debate: mrd, ready for primetime? - yes
-
2:31
what testing is most important to monitor your mds over time? #mds
-
14:34
debate: which initial therapy for younger fit patients is best? - cybord and bird
-
19:20
chip & icus: what do we know and what do we need to do?
-
6:30
opening day formal debate: first speaker against (...) - dorothy mbori-ngacha, mbchb, mmed, mph
-
12:00
debate: should we treat early-stage myelofibrosis? - yes, initiate therapy
-
21:18
myeloma debate: is mrd ready for prime time? - yes
-
1:45
momelotinib vs soc in patients with mf and anemia: an analysis from the simplify-2 trial
-
7:56
can transplantation improve survival rates for older patients with higher risk mds?
-
4:08
what treatment questions should i ask my doctor about my mds?
-
23:56
patient discussion i
-
23:32
genetic basis of mds
-
5:05
should minimal residual disease (mrd) testing be routinely performed?
-
1:54
risk-adapted therapy: three-day versus five-day oral decitabine in patients with mds